Reuters logo
BRIEF-Ironwood Reports Top-Line Phase IIa Data For IW-1973
December 4, 2017 / 1:18 PM / 12 days ago

BRIEF-Ironwood Reports Top-Line Phase IIa Data For IW-1973

Dec 4 (Reuters) - Ironwood Pharmaceuticals Inc:

* IRONWOOD REPORTS TOP-LINE PHASE IIA DATA FOR IW-1973 DEMONSTRATING POSITIVE CARDIOVASCULAR, METABOLIC AND ENDOTHELIAL EFFECTS

* IRONWOOD PHARMACEUTICALS INC - ‍IW-1973 WAS GENERALLY WELL-TOLERATED IN STUDY​

* IRONWOOD PHARMACEUTICALS INC - ‍ THERE WAS A SINGLE SERIOUS ADVERSE EVENT REPORTED IN ONE PATIENT TREATED WITH IW-1973​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below